Total Funding
61
58
Total FundingGrant raised
Growth Score 61 in past quarter
-3 pts
Heat Score 58 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
97583
Mendelian is helping doctors diagnose rare genetic diseases faster.
Rudi Airisto: Angel investorPast Role: Article, Director of Business Planning and Corporate Development- Peter Fish: CEO
About the Company
Mendelian is helping doctors diagnose rare genetic diseases faster. Mendelian uses patient’s clinical features to find genes responsible for rare diseases. Mendelian's intelligent agent parses patient's phenotypic features entered by a physician and outputs their causative genes and mutations. Thus offering a new way of investigating
undiagnosed cases.
